Rosen International
A debt market can tell an owner how much capital lenders will provide. It cannot decide how much liquidity the business should distribute without weakening the enterprise that must carry the debt afterward.
The Dividend Is the Easy Number to See
In June 2026, Rosen International planned an approximately $600 million shareholder dividend funded with an approximately $480 million add-on to its existing term loan B and roughly $121 million of cash. The recapitalization would push S&P Global Ratings-adjusted leverage to approximately 5.5x-6.0x in 2026, up from 5.2x in 2025.
The transaction creates a clean owner-level question. Rosen had improved operating performance, positive free operating cash flow, a fully undrawn revolver, and a term loan that lenders were willing to enlarge. Those facts support the ability to execute a recapitalization. They do not, by themselves, establish that $600 million is the prudent amount to remove from the company.
That distinction is the center of this case. A dividend recapitalization converts part of an owner’s accumulated enterprise value into cash without selling the business. The operating company keeps the assets, customers, technology and growth opportunity. It also keeps the incremental debt, interest burden and reduced cash cushion.
Reported transaction and credit figures in this case are drawn principally from S&P Global Ratings commentary. S&P figures are adjusted under its methodology and may differ from company-reported measures.
This Was Not Rosen’s First Dividend Recapitalization
Partners Group acquired Rosen in 2024 using a leveraged capital structure that initially included a $1.15 billion term loan B and a $300 million revolving credit facility. Later that year, Rosen raised a $375 million fungible add-on to the term loan to fund a sponsor dividend and transaction fees. That first recapitalization pushed expected year-end leverage to about 6.0x and slowed the deleveraging path that ratings analysts had previously expected.
Operating performance then improved. S&P reported 2024 revenue of $834 million, up 13% from 2023, and adjusted EBITDA of $366 million, up roughly 33%. In June 2025, the agency upgraded Rosen to B+ from B, citing improved profitability and a stronger track record. By 2025, Rosen generated an estimated $905 million of revenue and $295 million of S&P-adjusted EBITDA.
The second recapitalization therefore arrived after the business had demonstrated better operating resilience. It also returned leverage to a level that S&P considered stretched for the B+ rating, leading the agency to revise its outlook to negative in June 2026.
Advisory point: strong operating performance can create new debt capacity. The owner still has to decide whether that capacity should be harvested immediately or preserved as balance-sheet flexibility.
Sources and Uses: The Company Funds the Distribution
The economics of a dividend recap are straightforward. New borrowing and existing cash leave the operating company and become shareholder liquidity. There is no acquisition asset arriving on the other side of the balance sheet. The benefit is realized by ownership at closing; the repayment obligation remains with the enterprise.
| Source / Use | Approximate Amount | What It Means |
|---|---|---|
| Existing Term Loan B | ~$1.48B before the 2026 add-on | Senior secured debt already carried by the enterprise. |
| Incremental Term Loan B | ~$480M | New debt added specifically in connection with the 2026 shareholder distribution. |
| Cash on Hand | ~$121M | Existing corporate liquidity used alongside new borrowing. |
| Shareholder Dividend | ~$600M | Liquidity transferred from the enterprise to ownership. |
| Revolving Credit Facility | $300M, expected undrawn | Post-transaction liquidity backstop rather than a planned source for the dividend. |
The pro forma debt balance was expected to move into roughly the $1.9 billion-$2.0 billion range under S&P’s 2026 forecast. The company retained a $300 million revolver, and S&P assessed liquidity as adequate, with sources expected to exceed uses by more than 1.2x over the following 12 months.
The owner-liquidity question: a recapitalization can be financeable and still be aggressive. The relevant measure is not simply whether the lender funds the dividend. It is what remains inside the business after the cash leaves.
The Business Had Real Cash-Flow Support
Rosen is not a commodity producer whose cash flow rises and falls directly with the price of oil. It provides diagnostic systems, inspection services and engineering support for pipelines and other critical energy infrastructure. S&P described a business with a strong technology position, relatively low working-capital requirements and demand tied largely to customers’ operating-expense cycles.
That matters because the recapitalization was supported by more than lender appetite. S&P expected Rosen to grow revenue roughly 9%-11% during its forecast period, maintain adjusted EBITDA margins of 35%-37% in 2026-2027, and produce average free operating cash flow of about $120 million annually over those two years. The agency forecast 2026 free operating cash flow of $75 million-$125 million and 2027 free operating cash flow of $100 million-$150 million.
Rosen also continues to reinvest. S&P noted roughly $70 million of annual research and development spending and expected gross capital expenditure, including capitalized development costs, of approximately $100 million-$120 million over the next 12 months. Those expenditures are part of the reason the company’s technology position exists in the first place. They should not be treated as optional simply because a dividend is available.
IE Strategic view: free cash flow should be evaluated after the spending required to protect the franchise. A recapitalization that quietly assumes away necessary reinvestment overstates the cash available to ownership.
Interest Coverage Is Where the Leverage Becomes Real
Debt-to-EBITDA is useful, but it does not write the interest check. After the recapitalization, S&P expected FFO cash interest coverage of only 1.7x-2.2x in 2026 before improving to 2.2x-2.7x in 2027. The negative outlook specifically identified a failure to approach and sustain coverage above 2.5x as one condition that could pressure the rating.
Public fund filings also show Rosen’s term loan as floating-rate debt. A 2026 filing reported a Rosen term loan at three-month SOFR plus 2.25%, with a 5.92% coupon at the reporting date and a March 2031 maturity. That observation is useful for understanding rate sensitivity, but it should not be treated as a complete description of every post-recapitalization pricing term.
The company benefits from modest scheduled amortization. S&P expected only about $19 million of debt maturities over the following 12 months, representing term-loan amortization. That reduces immediate principal pressure, but it also means deleveraging depends primarily on EBITDA growth, retained cash generation and voluntary debt reduction rather than a heavy contractual amortization schedule.
Credit distinction: low mandatory amortization protects near-term liquidity. It does not reduce the economic leverage. The debt still has to be refinanced, repaid, or supported by a larger earnings base before maturity.
Liquidity Is Adequate. That Is Not the Same as Excess.
S&P’s April 2026 starting point included $176 million of cash, a fully undrawn $300 million revolver and expected cash funds from operations of roughly $200 million-$250 million. Against those sources, the agency identified approximately $19 million of debt amortization, $100 million-$120 million of gross capital expenditure, no material acquisitions, and the portion of the shareholder dividend not funded by the new term-loan add-on.
The revolver also contains a springing first-lien net leverage covenant of 9.1x, tested quarterly if at least 40% of the facility is drawn. S&P did not expect the revolver to be drawn under its base case.
That covenant provides substantial technical headroom relative to expected leverage. It should not be confused with an operating target. A company does not become prudently capitalized merely because it remains far inside a covenant designed to protect lenders under a different stress threshold.
Prudent capacity versus legal capacity: covenant headroom tells management how far the documents permit leverage to move. It does not tell ownership how much resilience should be surrendered voluntarily.
The Deleveraging Path Depends on Earnings Growth
S&P expected leverage to fall from 5.5x-6.0x in 2026 to 4.7x-5.2x in 2027 while debt remained broadly in the $1.9 billion-$2.0 billion range. That forecast reveals an important feature of the recapitalization: much of the expected improvement comes from a larger EBITDA denominator rather than a dramatic reduction in absolute debt.
The agency expected adjusted EBITDA to average $350 million-$400 million during 2026-2027, compared with $295 million in 2025. Its forecast assumed roughly 10% revenue growth, continued pricing initiatives, stable 35%-37% adjusted EBITDA margins, minimal working-capital requirements and no further acquisitions or dividends during the forecast period.
Those assumptions are plausible given Rosen’s recent performance and market position. They are still assumptions the capital structure now relies upon. The more owner liquidity extracted at closing, the more important it becomes that EBITDA growth arrives on schedule.
The recap trade: ownership receives certainty today. The enterprise gives up some of its ability to absorb a weaker tomorrow.
What Could Compromise Enterprise Resilience?
EBITDA Miss
The expected leverage decline depends heavily on earnings expansion. Slower volume, pricing pressure or execution problems would keep leverage elevated for longer.
Interest Burden
Floating-rate debt keeps cash interest sensitive to the rate environment. Coverage already sits closer to the rating agency’s downside threshold immediately after the recapitalization.
Repeated Releveraging
The 2026 transaction is the second sponsor dividend recapitalization since the 2024 buyout. Additional debt-funded distributions would weaken the credibility of the projected deleveraging path.
Reinvestment Pressure
Technology, diagnostic systems, data capabilities and R&D support Rosen’s competitive position. Cutting necessary investment to defend cash flow would weaken the asset that supports the debt.
Refinancing Risk
Modest amortization limits near-term principal demands but leaves a large debt balance outstanding. Market access matters when the 2031 maturity approaches.
End-Market Change
Pipeline integrity work benefits from regulation and an aging infrastructure base, but long-term energy-transition dynamics remain relevant to demand and valuation.
Downside: The Dividend Is Already Gone
A recapitalization has an asymmetry that deserves attention. Once the shareholder distribution is made, a later operating shortfall does not bring that cash back into the company. The enterprise has to manage the weaker case with the post-transaction balance sheet.
Base Case
Revenue continues to grow near the expected rate, margins remain strong, free operating cash flow stays positive, no additional distributions are made, and leverage moves toward 5.0x or below during 2027. The dividend converts owner value into liquidity without materially impairing the operating plan.
Downside
EBITDA growth arrives more slowly and interest coverage remains around the lower end of the expected range. Liquidity remains workable because the revolver is undrawn and amortization is light, but debt reduction is delayed and the company enters refinancing discussions with less flexibility.
Severe Downside
Operating setbacks hold leverage above 5.0x for an extended period while FFO cash interest coverage fails to approach 2.5x. A second problem – acquisition spending, another distribution, higher rates or weaker demand – would then arrive against a balance sheet with materially less room to absorb it.
Decision trigger: the recapitalization becomes materially less comfortable if the business needs uninterrupted EBITDA growth simply to restore leverage to a level that was already considered appropriate before the dividend.
IE Strategic Advisory Conclusion
Rosen demonstrates why debt availability and prudent debt capacity are different questions. The company entered the 2026 recapitalization with real strengths: a leading technical position, strong recent operating performance, positive free operating cash flow, low working-capital intensity, an undrawn revolver and limited near-term amortization. Those characteristics make a shareholder distribution economically understandable.
The amount of the distribution is more debatable than the concept. Approximately $600 million of owner liquidity is large relative to Rosen’s expected annual free operating cash flow and pushes leverage back toward 6.0x only two years after the sponsor acquisition. The resulting balance sheet remains financeable under the published base case, but the cushion narrows because the deleveraging story depends substantially on EBITDA growth rather than rapid absolute debt reduction.
For an owner-led company considering the same decision, the useful lesson is not that dividend recaps are inherently aggressive. It is that the maximum amount lenders will fund should rarely be treated as the target distribution. The better question is how much liquidity can be created while leaving the company able to absorb a missed year, continue necessary investment, preserve negotiating leverage with lenders and refinance without needing the capital markets to be perfectly cooperative.
Our decision standard: owner liquidity is prudent when the enterprise can still carry its debt through a credible downside without sacrificing core reinvestment or depending on immediate EBITDA growth to repair the balance sheet. If the recapitalization removes that room, the distribution has moved from monetizing value to borrowing resilience from the future.
Reported Facts vs. IE Strategic Analysis
Reported facts in this case include the announced 2026 dividend recapitalization, term-loan add-on, cash contribution, S&P-adjusted leverage and cash-flow forecasts, liquidity assessment, revolver capacity, covenant threshold, historical rating actions and company operating information.
IE Strategic analysis includes the owner-liquidity framing, the distinction between financeable and prudent leverage, the base/downside/severe-downside interpretation, the assessment of which variables matter most to enterprise resilience, and the advisory conclusion above. We do not present undisclosed sponsor returns, private company financial statements, exact future interest expense or unreported post-transaction balances as facts.
Primary Sources
- S&P Global Ratings – Rosen International outlook revised to negative on debt-funded dividend recapitalization – June 23, 2026
- S&P Global Ratings – Rosen upgraded to B+ on improving profitability and track record – June 26, 2025
- S&P Global Ratings – Rosen outlook revised to stable on 2024 term-loan add-on and sponsor dividend – October 11, 2024
- S&P Global Ratings – Rosen acquisition financing and preliminary ratings – February 12, 2024
- ROSEN Group – company and operating profile – April 24, 2026
- Invesco Senior Loan Fund filing – Rosen term-loan pricing and maturity observation – 2026
Source links are provided so readers can distinguish the public credit and operating record from IE Strategic Capital Group’s analysis. Ratings-agency figures reflect the agency’s own adjustments and definitions.
Owner Liquidity Should Not Come at the Expense of Operating Flexibility
IE Strategic Capital Group works with owners evaluating recapitalizations, debt capacity, shareholder liquidity and capital structures where the amount available to borrow is only the beginning of the decision.
Start a Confidential ConversationImportant Note
This case study is provided for informational and educational purposes and reflects IE Strategic Capital Group’s independent analysis of publicly available information. Certain observations, scenarios, and conclusions involve analytical judgment and should be considered in that context. The discussion is intended to illustrate an advisory underwriting framework and should not be relied upon as investment, legal, tax, accounting, or transaction advice.